KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Depreciation and Depletion: 2009-2025

Historic Depreciation and Depletion for Neogenomics (NEO) over the last 17 years, with Sep 2025 value amounting to $8.8 million.

  • Neogenomics' Depreciation and Depletion fell 8.52% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.1 million, marking a year-over-year decrease of 4.42%. This contributed to the annual value of $39.1 million for FY2024, which is 4.41% up from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Depreciation and Depletion is $8.8 million, which was down 3.69% from $9.1 million recorded in Q2 2025.
  • Neogenomics' Depreciation and Depletion's 5-year high stood at $9.9 million during Q1 2024, with a 5-year trough of $6.7 million in Q1 2021.
  • Its 3-year average for Depreciation and Depletion is $9.4 million, with a median of $9.5 million in 2023.
  • In the last 5 years, Neogenomics' Depreciation and Depletion grew by 25.67% in 2022 and then dropped by 8.52% in 2025.
  • Neogenomics' Depreciation and Depletion (Quarterly) stood at $8.4 million in 2021, then grew by 13.04% to $9.5 million in 2022, then grew by 1.06% to $9.6 million in 2023, then grew by 2.60% to $9.8 million in 2024, then decreased by 8.52% to $8.8 million in 2025.
  • Its last three reported values are $8.8 million in Q3 2025, $9.1 million for Q2 2025, and $9.4 million during Q1 2025.